Patents by Inventor Annabelle REAUX-LE GOAZIGO

Annabelle REAUX-LE GOAZIGO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminophosphinic derivatives for preventing and treating eye inflammation
    Patent number: 11090317
    Abstract: The disclosure relates to compounds of formula (I): R1-NH—CH(R2)-P(?O)(OH)—CH2-C(R3)(R4)-CONH—C(R5)(R6)-COOR7, where R1 to R7 are as defined in the claims, for use of same in the treatment and/or prevention of ocular inflammation, and more particularly for improving the process of ocular healing. Thus, the compounds of formula (I) are used, in particular, to prevent neovascularisation, or to prevent or treat an ocular inflammation linked to a keratitis, scleritis, episcleritis, uveitis, cataract, synechia, macular oedema, detachment of the retina, ocular hypertension and degeneration of the optical nerve caused by glaucoma.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: August 17, 2021
    Assignee: Pharmaleads
    Inventors: Hervé Poras, Michel Wurm, Stéphane Melik Parsadaniantz, Annabelle Reaux-Le Goazigo
  • AMINOPHOSPHINIC DERIVATIVES FOR PREVENTING AND TREATING EYE INFLAMMATION
    Publication number: 20210213036
    Abstract: The disclosure relates to compounds of formula (I): R1-NH—CH(R2)-P(?O)(OH)—CH2-C(R3)(R4)-CONH—C(R5)(R6)-COOR7, where R1 to R7 are as defined in the claims, for use of same in the treatment and/or prevention of ocular inflammation, and more particularly for improving the process of ocular healing. Thus, the compounds of formula (I) are used, in particular, to prevent neovascularisation, or to prevent or treat an ocular inflammation linked to a keratitis, scleritis, episcleritis, uveitis, cataract, synechia, macular oedema, detachment of the retina, ocular hypertension and degeneration of the optical nerve caused by glaucoma.
    Type: Application
    Filed: March 9, 2018
    Publication date: July 15, 2021
    Applicant: PHARMALEADS
    Inventors: Hervé PORAS, Michel WURM, Stéphane MELIK PARSADANIANTZ, Annabelle REAUX-LE GOAZIGO
  • Methods of treating eye pain with aminophosphinic derivatives
    Patent number: 10688113
    Abstract: The disclosure relates to a method of treating or preventing eye pain in a subject in need thereof. The method includes administering a compound of formula (I), R1—NH—CH(R2)—P(?O)(OH)—CH2—C(R3)(R4)—CONH—C(R5)(R6)—COOR7, to the subject.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: June 23, 2020
    Assignee: PHARMALEADS
    Inventors: Hervé Poras, Michel Wurm, Stéphane Melik Parsadaniantz, Annabelle Reaux-Le Goazigo
  • Methods of Treating Eye Pain With Aminophosphinic Derivatives
    Publication number: 20190167701
    Abstract: The disclosure relates to a method of treating or preventing eye pain in a subject in need thereof. The method includes administering a compound of formula (I), R1—NH—CH(R2)—P(?O)(OH)—CH2—C(R3)(R4)—CONH—C(R5)(R6)—COOR7, to the subject.
    Type: Application
    Filed: February 11, 2019
    Publication date: June 6, 2019
    Applicant: PHARMALEADS
    Inventors: Hervé PORAS, Michel WURM, Stéphane MELIK PARSADANIANTZ, Annabelle REAUX-LE GOAZIGO
  • AMINOPHOSPHINIC DERIVATIVES FOR PREVENTING AND TREATING EYE PAIN
    Publication number: 20180344753
    Abstract: The disclosure relates to formula (I) compounds R1-NH—CH(R2)-P(=0)(OH)—CH2-C(R3)(R4)-CONH—C(R5)(R6)-COOR7 for the use thereof in treating and/or preventing eye pain.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 6, 2018
    Applicant: PHARMALEADS
    Inventors: Hervé PORAS, Michel WURM, Stéphane MELIK PARSADANIANTZ, Annabelle REAUX-LE GOAZIGO